Eliezer Jesus Barreiro (Eliezer J Barreiro)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Venues

Pharmaceuticals (Basel, Switzerland)

Pharmaceutics

Biomedicines

Journal of medicinal chemistry

Federal University of Rio de Janeiro/LASSBio

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Federal University of Rio de Janeiro/LASSBio

Brazil

Full Professor :: LASSBio

Publications

Amanda Aparecida Ribeiro Andrade, Fernanda Pauli, Carolina Girotto Pressete, Bruno Zavan, João Adolfo Costa Hanemann, Marta Miyazawa, Rafael Fonseca, Ester Siqueira Caixeta, Julia Louise Moreira Nacif, Alexandre Ferro Aissa, Eliezer Jesus Barreiro, Marisa Ionta
Antiproliferative Activity of N -Acylhydrazone Derivative on Hepatocellular Carcinoma Cells Involves Transcriptional Regulation of Genes Required for G2/M Transition. Biomedicines 12 (4) (2024)
Amanda Aparecida Ribeiro Andrade, Fernanda Pauli, Carolina Girotto Pressete, Bruno Zavan, João Adolfo Costa Hanemann, Marta Miyazawa, Rafael Fonseca, Ester Siqueira Caixeta, Julia Louise Moreira Nacif, Alexandre Ferro Aissa, Eliezer Jesus Barreiro, Marisa Ionta
Antiproliferative Activity of N -Acylhydrazone Derivative on Hepatocellular Carcinoma Cells Involves Transcriptional Regulation of Genes Required for G2/M Transition. Biomedicines 12 (4) (2024)
Eduardo Reina, Lucas Silva Franco, Teiliane Rodrigues Carneiro, Eliezer Jesus Barreiro, Lidia Moreira Lima
Stereochemical insights into β-amino- N -acylhydrazones and their impact on DPP-4 inhibition. RSC advances 14 (10) (2024)
Raysa Magali Pillpe-Meza, Wesley Leandro Gouveia, Gisele Barbosa, Carlos Alberto Manssour Fraga, Eliezer Jesus Barreiro, Lidia Moreira Lima
Cytotoxic and Antiproliferative Activity of LASSBio-2208 and the Attempts to Determine Its Drug Metabolism and Pharmacokinetics In Vitro Profile. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Eduardo Reina, Lucas Silva Franco, Teiliane Rodrigues Carneiro, Eliezer Jesus Barreiro, Lidia Moreira Lima
Stereochemical insights into β-amino- N -acylhydrazones and their impact on DPP-4 inhibition. RSC advances 14 (10) (2024)
Raysa Magali Pillpe-Meza, Wesley Leandro Gouveia, Gisele Barbosa, Carlos Alberto Manssour Fraga, Eliezer Jesus Barreiro, Lidia Moreira Lima
Cytotoxic and Antiproliferative Activity of LASSBio-2208 and the Attempts to Determine Its Drug Metabolism and Pharmacokinetics In Vitro Profile. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Raysa Magali Pillpe-Meza, Wesley Leandro Gouveia, Gisele Barbosa, Carlos Alberto Manssour Fraga, Eliezer Jesus Barreiro, Lidia Moreira Lima
Cytotoxic and Antiproliferative Activity of LASSBio-2208 and the Attempts to Determine Its Drug Metabolism and Pharmacokinetics In Vitro Profile. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Caroline Marques Xavier Costa, Cristiane Aparecida-Silva, Luis Eduardo Reina Gamba, Thalita Neves de Melo, Gisele Barbosa, Manoel Oliveira de Moraes Junior, Victoria Regina Thomaz de Oliveira, Carolinne Souza de Amorim, João Alfredo de Moraes, Eliezer Jesus Barreiro, Lidia Moreira Lima
Design, Synthesis and Phenotypic Profiling of Simplified Gedatolisib Analogues. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Celina de Jesus Guimarães, Teiliane Rodrigues Carneiro, Marisa Jadna Silva Frederico, Guilherme G C de Carvalho, Matthew Little, Valder N Freire, Victor L B França, Daniel Nascimento do Amaral, Jéssica de Siqueira Guedes, Eliezer Jesus Barreiro, Lidia Moreira Lima, Francisco W A Barros-Nepomuceno, Cláudia do Ó Pessoa
Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer Agent. Pharmaceutics 15 (4) (2023)
Celina de Jesus Guimarães, Teiliane Rodrigues Carneiro, Marisa Jadna Silva Frederico, Guilherme G C de Carvalho, Matthew Little, Valder N Freire, Victor L B França, Daniel Nascimento do Amaral, Jéssica de Siqueira Guedes, Eliezer Jesus Barreiro, Lidia Moreira Lima, Francisco W A Barros-Nepomuceno, Cláudia do Ó Pessoa
Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer Agent. Pharmaceutics 15 (4) (2023)
Celina de Jesus Guimarães, Teiliane Rodrigues Carneiro, Marisa Jadna Silva Frederico, Guilherme G C de Carvalho, Matthew Little, Valder N Freire, Victor L B França, Daniel Nascimento do Amaral, Jéssica de Siqueira Guedes, Eliezer Jesus Barreiro, Lidia Moreira Lima, Francisco W A Barros-Nepomuceno, Cláudia do Ó Pessoa
Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer Agent. Pharmaceutics 15 (4) (2023)
Celina de Jesus Guimarães, Teiliane Rodrigues Carneiro, Marisa Jadna Silva Frederico, Guilherme G C de Carvalho, Matthew Little, Valder N Freire, Victor L B França, Daniel Nascimento do Amaral, Jéssica de Siqueira Guedes, Eliezer Jesus Barreiro, Lidia Moreira Lima, Francisco W A Barros-Nepomuceno, Cláudia do Ó Pessoa
Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer Agent. Pharmaceutics 15 (4) (2023)
Gisele Barbosa, Luis Gabriel Valdivieso Gelves, Caroline Marques Xavier Costa, Lucas Silva Franco, João Alberto Lins de Lima, Cristiane Aparecida-Silva, John Douglas Teixeira, Claudia Dos Santos Mermelstein, Eliezer Jesus Barreiro, Lidia Moreira Lima
Discovery of Putative Dual Inhibitor of Tubulin and EGFR by Phenotypic Approach on LASSBio-1586 Homologs. Pharmaceuticals (Basel, Switzerland) 15 (8) (2022)
Jéssica de Siqueira Guedes, Teiliane Rodrigues Carneiro, Pedro de Sena Murteira Pinheiro, Carlos Alberto Manssour Fraga, Carlos Mauricio R Sant Anna, Eliezer Jesus Barreiro, Lidia Moreira Lima
Methyl Effect on the Metabolism, Chemical Stability, and Permeability Profile of Bioactive N -Sulfonylhydrazones. ACS omega 7 (43) (2022)
Max Denisson Maurício Viana, Alyne Almeida de Lima, Geraldo José da Silva Neto, Suellen Maria Albuquerque da Silva, Anderson Brandão Leite, Elane Conceição Dos Santos, Ênio José Bassi, Eliane Aparecida Campesatto, Aline Cavalcanti de Queiroz, Eliezer Jesus Barreiro, Lidia Moreira Lima, Magna Suzana A Moreira
LASSBio-596: a New Pre-clinical Candidate for Rheumatoid Arthritis? Inflammation (2021)
Júlia Galvez Bulhões Pedreira, Rafaela Ribeiro Silva, François G Noël, Eliezer Jesus Barreiro
Effect of S-Se Bioisosteric Exchange on Affinity and Intrinsic Efficacy of Novel N-acylhydrazone Derivatives at the Adenosine A2A Receptor. Molecules (Basel, Switzerland) 26 (23) (2021)
Gizele Cabral Costa, Tadeu Lima Montagnoli, Jaqueline Soares da Silva, Allan Kardec Nogueira de Alencar, Luis Eduardo Reina Gamba, Bryelle Eccard Oliveira Alves, Marina Moraes Carvalho da Silva, Margarete Manhães Trachez, Jose Hamilton Matheus Nascimento, Pedro Moreno Pimentel-Coelho, Rosália Mendez-Otero, Lidia Moreira Lima, Eliezer Jesus Barreiro, Roberto Takashi Sudo, Gisele Zapata-Sudo
New Benzofuran N-Acylhydrazone Reduces Cardiovascular Dysfunction in Obese Rats by Blocking TNF-Alpha Synthesis. Drug design, development and therapy 14 (2020)
Lucas Silva Franco, Rodolfo C Maia, Eliezer Jesus Barreiro
Identification of LASSBio-1945 as an inhibitor of SARS-CoV-2 main protease (MPRO) through in silico screening supported by molecular docking and a fragment-based pharmacophore model. RSC medicinal chemistry 12 (1) (2020)
Fernanda P Pauli, Juliana R Martins, Thaysa Paschoalin, Marisa Ionta, Maria Leticia C Barbosa, Eliezer Jesus Barreiro
Novel VEGFR-2 inhibitors with an N-acylhydrazone scaffold. Archiv der Pharmazie 353 (11) (2020)
Júlia G B Pedreira, Philipp Nahidino, Mark Kudolo, Tatu Pantsar, Benedict-Tilmann Berger, Michael Forster, Stefan Knapp, Stefan A Laufer, Eliezer Jesus Barreiro
Bioisosteric Replacement of Arylamide-Linked Spine Residues with N-Acylhydrazones and Selenophenes as a Design Strategy to Novel Dibenzosuberone Derivatives as Type I 1/2 p38α MAP Kinase Inhibitors. Journal of medicinal chemistry 63 (13) (2020)
Eliezer Jesus Barreiro
What is hidden in the biodiversity? The role of natural products and medicinal chemistry in the drug discovery process. Anais da Academia Brasileira de Ciencias 91 (supp 3) (2019)
Sreekanth Thota, Daniel A Rodrigues, Debbie C Crans, Eliezer Jesus Barreiro
Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics? Journal of medicinal chemistry 61 (14) (2018)

Eliezer Jesus Barreiro.css-eqlu8i{font-size:small;padding-left:4px;} (Eliezer J Barreiro)

Publication Activity (10 Years)

Top Topics

Top Venues

Eliezer Jesus Barreiro (Eliezer J Barreiro)